Clinical trial
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced…
NCT00492440 · Cytheris SA, Industry · Terminated
Key facts
| NCT number | NCT00492440 |
|---|---|
| Title | Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer |
| Official title | A Phase I Study of Subcutaneous "CYT 107" (Interleukin-7) in Refractory Metastatic Melanoma or Renal Cell Carcinoma |
| Lead sponsor | Cytheris SA, Industry |
| Collaborators | Cytheris, Inc. Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Melanoma (Skin) |
| Intervention type | Biological, Genetic, Other |
| Interventions | recombinant interleukin-7, gene expression analysis, polymerase chain reaction, protein expression analysis, flow cytometry, immunoenzyme technique, immunologic technique, laboratory biomarker analysis, pharmacological study |
| Enrollment | 9 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jun 27, 2007 |
| Last update posted | Oct 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: